510 related articles for article (PubMed ID: 31593800)
1. Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel.
Shen Z; Zhou L; Zhang C; Xu J
Cancer Lett; 2020 Jan; 468():88-101. PubMed ID: 31593800
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA circFOXO3 promotes prostate cancer progression through sponging miR-29a-3p.
Kong Z; Wan X; Lu Y; Zhang Y; Huang Y; Xu Y; Liu Y; Zhao P; Xiang X; Li L; Li Y
J Cell Mol Med; 2020 Jan; 24(1):799-813. PubMed ID: 31733095
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-223-3p regulates cell chemo-sensitivity by targeting FOXO3 in prostatic cancer.
Feng Q; He P; Wang Y
Gene; 2018 Jun; 658():152-158. PubMed ID: 29518547
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circFoxo3 Promotes Granulosa Cell Apoptosis Under Oxidative Stress Through Regulation of FOXO3 Protein.
Chen L; Zhu L; Fang J; Zhang N; Li D; Sheng X; Zhou J; Wang S; Wang J
DNA Cell Biol; 2022 Dec; 41(12):1026-1037. PubMed ID: 36394459
[TBL] [Abstract][Full Text] [Related]
5. The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.
Hanrahan K; O'Neill A; Prencipe M; Bugler J; Murphy L; Fabre A; Puhr M; Culig Z; Murphy K; Watson RW
Mol Oncol; 2017 Mar; 11(3):251-265. PubMed ID: 28133913
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1.
Hong X; Liu N; Liang Y; He Q; Yang X; Lei Y; Zhang P; Zhao Y; He S; Wang Y; Li J; Li Q; Ma J; Li Y
Mol Cancer; 2020 Feb; 19(1):33. PubMed ID: 32061262
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer.
Marín-Aguilera M; Codony-Servat J; Reig Ò; Lozano JJ; Fernández PL; Pereira MV; Jiménez N; Donovan M; Puig P; Mengual L; Bermudo R; Font A; Gallardo E; Ribal MJ; Alcaraz A; Gascón P; Mellado B
Mol Cancer Ther; 2014 May; 13(5):1270-84. PubMed ID: 24659820
[TBL] [Abstract][Full Text] [Related]
8. NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway.
Luo S; Shao L; Chen Z; Hu D; Jiang L; Tang W
Exp Cell Res; 2020 May; 390(2):111981. PubMed ID: 32234375
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.
Pan Y; Chen J; Tao L; Zhang K; Wang R; Chu X; Chen L
Oncotarget; 2017 May; 8(20):33144-33158. PubMed ID: 28388536
[TBL] [Abstract][Full Text] [Related]
10. CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5.
Zhang S; Liao K; Miao Z; Wang Q; Miao Y; Guo Z; Qiu Y; Chen B; Ren L; Wei Z; Lin Y; Lu X; Qiu Y
Neuro Oncol; 2019 Oct; 21(10):1284-1296. PubMed ID: 31504797
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor ZEB1 promotes chemoresistance in prostate cancer cell lines.
Orellana-Serradell O; Herrera D; Castellón EA; Contreras HR
Asian J Androl; 2019; 21(5):460-467. PubMed ID: 30880686
[TBL] [Abstract][Full Text] [Related]
12. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
Alshaker H; Wang Q; Kawano Y; Arafat T; Böhler T; Winkler M; Cooper C; Pchejetski D
Oncotarget; 2016 Dec; 7(49):80943-80956. PubMed ID: 27821815
[TBL] [Abstract][Full Text] [Related]
13. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1.
Zhang G; Tian X; Li Y; Wang Z; Li X; Zhu C
Biomed Pharmacother; 2018 Jan; 97():736-744. PubMed ID: 29102917
[TBL] [Abstract][Full Text] [Related]
14. CircFOXO3 functions as a molecular sponge for miR-143-3p to promote the progression of gastric carcinoma via upregulating USP44.
Xiang T; Jiang HS; Zhang BT; Liu G
Gene; 2020 Aug; 753():144798. PubMed ID: 32445925
[TBL] [Abstract][Full Text] [Related]
15. Identification of the tumor‑suppressive role of circular RNA‑FOXO3 in colorectal cancer via regulation of miR‑543/LATS1 axis.
Deng YY; Min YJ; Zhou K; Yang QS; Peng M; Cui ZR; Zhu XL; Liu H; Wang M; Zhang X; Liu LX
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34549306
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of circFOXO3 ameliorates cigarette smoke-induced lung injury in mice.
Zhou L; Wu B; Yang J; Wang B; Pan J; Xu D; Du C
Respir Res; 2021 Nov; 22(1):294. PubMed ID: 34789242
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
18. CircFOXO3 protects against osteoarthritis by targeting its parental gene FOXO3 and activating PI3K/AKT-mediated autophagy.
Zhao C; Li X; Sun G; Liu P; Kong K; Chen X; Yang F; Wang X
Cell Death Dis; 2022 Nov; 13(11):932. PubMed ID: 36344492
[TBL] [Abstract][Full Text] [Related]
19. TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization.
Li Y; Zhang B; Xiang L; Xia S; Kucuk O; Deng X; Boise LH; Dong JT
Theranostics; 2020; 10(17):7656-7670. PubMed ID: 32685011
[TBL] [Abstract][Full Text] [Related]
20. Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism.
Chen L; Song Y; Hou T; Li X; Cheng L; Li Y; Xing Y
J Exp Clin Cancer Res; 2022 Jun; 41(1):194. PubMed ID: 35659274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
